menu
{ "item_title" : "The Pharmaceutical Regulatory Process", "item_author" : [" Ira R. Berry", "Robert P. Martin "], "item_description" : "This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval.New chapters cover:the marketing of unapproved new drugs and FDA efforts to keep them in regulatory compliancepharmacovigilance programs designed to prevent widespread safety issueslegal issues surrounding the sourcing of foreign APIsthe issues of counterfeit drugsupdates on quality standards", "item_img_path" : "https://covers2.booksamillion.com/covers/bam/1/13/838/128/1138381284_b.jpg", "price_data" : { "retail_price" : "87.99", "online_price" : "87.99", "our_price" : "87.99", "club_price" : "87.99", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
The Pharmaceutical Regulatory Process|Ira R. Berry

The Pharmaceutical Regulatory Process

local_shippingShip to Me
Earliest ship date: May 18, 2026
FREE Shipping for Club Members help

Overview

This Second Edition examines the mechanisms and means to establish regulatory compliance for pharmaceutical products and company practices. It focuses on major legislative revisions that impact requirements for drug safety reviews, product regulatory approvals, and marketing practices. Written by top industry professionals, practicing attorneys, and FDA regulators, it includes policies and procedures that pharmaceutical companies need to implement regulatory compliance post-approval.

New chapters cover:

  • the marketing of unapproved new drugs and FDA efforts to keep them in regulatory compliance
  • pharmacovigilance programs designed to prevent widespread safety issues
  • legal issues surrounding the sourcing of foreign APIs
  • the issues of counterfeit drugs
  • updates on quality standards

This item is Non-Returnable

Details

  • ISBN-13: 9781138381285
  • ISBN-10: 1138381284
  • Publisher: CRC Press
  • Publish Date: June 2019
  • Page Count: 492

Related Categories

You May Also Like...

    1

BAM Customer Reviews